logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hideaki Bando

National Cancer Center Hospital East
H指数:42
被引数:7,335

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Discordance between RNA-identified ETV6::RET and clinically reportable DNA profiling in salivary gland secretory carcinoma

病例报告：涎腺分泌性癌中RNA鉴定ETV6::RET与临床可报告的DNA分型之间的不一致

Frontiers in Oncology
IF3.3
2026-09-280
OA
SB Shogen Boku; TF Takao Fujisawa; TS Tomofumi Sakagami; SK Shigenori Kadowaki; HS Hironaga Satake; HY Hisateru Yasui; KO Koushiro Ohtsubo; YS Yasushi Shimizu; TO Tomoyuki Otsuka; BK Bunya Kuze; RY Riu Yamashita; TS Taro Shibuki; YN Yoshiaki Nakamura; HB Hideaki Bando; TY Takayuki Yoshino; MR Milan Radovich; MY Masao Yagi; SO Susumu Okano
Landscape of cancer genomics and precision oncology in Japan, South Korea, China, and Australia

日本、韩国、中国和澳大利亚癌症基因组学与精准肿瘤学的现状

Lancet Regional Health-Western Pacific
IF8.1
2026-09-100
OAAI
Hideaki Bando; Hirokazu Okayama; Yoon Jung Chang; Jinpu Yu; Sean M. Grimmond; Sun-Young Kong; Xin Hu; Nikolajs Zeps; Ji-Youn Han; Jong-Il Kim; Kyosuke Seguchi; Masataka Amisaki; Yasutoshi Sakamoto; Takao Fujisawa; Riu Yamashita; Kazuto Kato; Koji Kono; Amber Johns; Takayuki Yoshino
Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用：一项前瞻性单臂II期临床试验

Communications Medicine
IF6.3
2026-09-090
OAAI
Yoshinori Kagawa; Daisuke Kotani; Hiroya Taniguchi; Tadayoshi Hashimoto; Hideaki Bando; Naoki Takahashi; Tetsuya Hamaguchi; Akiyoshi Kanazawa; Takeshi Kato; Koji Ando; Hisateru Yasui; Eiji Shinozaki; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Satoshi Yuki; Yoshiaki Nakamura; Masashi Wakabayashi; Hiromichi Nakajima; Takashi Ohta; Takayuki Yoshino
Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-derived external control arms

转移性结直肠癌随机试验中基于ARCAD衍生外部对照臂的总体生存期可重复性

JNCI: Journal of the National Cancer Institute
IF0
2026-08-220
PRE
Morteza Raeisi, PhD; Thierry André, MD; Qian Shi, PhD; Takayuki Yoshino, MD, PhD; Richard Adams, MD; Chiara Cremolini, MD; Jeffrey A Meyerhardt, MD; Jeanne Tie, MD; Romain Cohen, MD, PhD; Jean-Baptiste Bachet, MD; Hideaki Bando, MD, PhD; Toshihiro Misumi, PhD; Carsten Bokemeyer, MD; Leonard B Saltz, MD; Miriam Koopman, MD; Volker Heinemann, MD; Marc Peeters, MD, PhD; Eric Van Cutsem, MD, PhD; Axel Grothey, MD; Benoist Chibaudel, MD; Aimery de Gramont, MD
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer

WES定义的ERBB2扩增在可切除结直肠癌中的临床意义

International Journal of Clinical Oncology
IF2.8
2026-08-200
OAAI
Kazuki Kishi; Atsushi Hamabe; Yusuke Suwa; Naoya Akazawa; Keiji Hirata; Masataka Ikeda; Mitsuru Yokota; Kentaro Kato; Masahito Kotaka; Yujiro Nishizawa; Hideaki Bando; Yoshiaki Nakamura; Saori Mishima; Tadayoshi Hashimoto; Arkarachai Fungtammasan; Charuta C. Palsuledesai; Robert W. Lentz; Daisuke Kotani; Hiroya Taniguchi; Jun Watanabe; Ichiro Takemasa; Takeshi Kato; Mamoru Uemura; Hidetoshi Eguchi; Yuichiro Doki; Eiji Oki; Takayuki Yoshino
Mapping the Anatomical Landscape of Colorectal Tumours: Location-Specific Efficacy of Anti-Epidermal Growth Factor Receptor Antibodies: Pooled Analysis of Randomised Trials

绘制结直肠癌解剖景观：抗表皮生长因子受体抗体位置特异性疗效：随机试验的合并分析

European Journal of Cancer
IF7.1
2026-06-120
PRE
Kenta Iguchi; Kentaro Yamazaki; Toshihiro Misumi; Hideaki Bando; Yuka Nishimura; Tomomi Nishikawa; Eiji Oki; Jean-Yves Douillard; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Yoshihiko Maehara; Volker Heinemann; Chiara Cremolini; Goro Nakayama; Thierry André; Qian Shi; Aimery de Gramont; Takayuki Yoshino
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

Nature Medicine
IF50
2026-06-080
OAAI
Hideaki Bando; Jun Watanabe; Yusuke Takahashi; Masahito Kotaka; Nobuhisa Matsuhashi; Eiji Oki; Yoshito Komatsu; Manabu Shiozawa; Keiji Hirata; Yuji Miyamoto; Masanobu Takahashi; Kentaro Yamazaki; Dai Manaka; Akiyoshi Kanazawa; Yi-Hsin Liang; Kun-Huei Yeh; Yuko Watsuji; Yuko Yamamoto; Makoto Fukui; Shruti Sharma; Vasily N. Aushev; Adham Jurdi; Matthew Rabinowitz; Minetta C. Liu; Alexey Aleshin; Ichiro Takemasa; Daisuke Kotani; Akihiro Sato; Toshihiro Misumi; Yoshiaki Nakamura; Qian Shi; Hiroya Taniguchi; Takayuki Yoshino; Takeshi Kato
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial

PALADIN试验：一项关于短程放疗联合化疗作为不可切除局部晚期食管鳞状细胞癌诱导治疗的帕博利珠单抗的II期研究

ESMO Gastrointestinal Oncology
IF0
2026-06-010
OA
Okemoto, D.; Kotani, D.; Nakamura, M.; Sato, K.; Kubo, Y.; Kadota, T.; Mishima, S.; Sakashita, S.; Hashimoto, T.; Bando, H.; Wakabayashi, M.; Rabinowitz, M.; Liu, M. C.; Jurdi, A.; Yamaguchi, T.; Nishikawa, H.; Shitara, K.; Yano, T.; Kojima, T.; Fujita, Takeo
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway

既往抗EGFR治疗和基线ctDNA分析对帕妥珠单抗联合曲妥珠单抗在HER2扩增转移性结直肠癌中的疗效影响：TRIUMPH/MyPathway整合分析

ESMO Open
IF8.3
2026-05-270
OAAI
Y. Matsubara; M. Wakabayashi; W. Okamoto; T. Kato; T. Esaki; K. Kato; Y. Komatsu; T. Masuishi; T. Nishina; H. Bando; T. Misumi; M. Fukui; S. Matsuda; Y. Ikeda; J. Malato; K. Schulze; R. Price; A. Sato; T. Yoshino; Y. Nakamura
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究：BRAVERY研究（EPOC1701）

ESMO Open
IF8.3
2025-10-090
OAAI
T. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study

随着奥沙利铂为基础的化疗联合靶向药物，转移性结直肠癌的生存率随时间推移呈逐年改善：一项ARCAD数据库研究

European Journal of Cancer
IF7.1
2025-10-020
OAAI
Kazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer

CLDN18.2阳性胃癌患者接受含zolbetuximab化疗期间早期胃炎的特征分析

ESMO Open
IF8.3
2025-09-300
OAAI
K. Yamamoto; Y. Owaki; I. Nakayama; N. Sakamoto; M. Ishizaka; T. Kadota; D. Okemoto; Y. Matsubara; Y. Miyashita; A. Kobayashi; U. Okazaki; K. Seguchi; T. Hosokai; T. Ogura; S. Mishima; D. Kotani; A. Kawazoe; T. Hashimoto; Y. Kuboki; H. Bando; T. Kojima; T. Yoshino; T. Kuwata; G. Ishii; T. Yano; K. Shitara
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究：一项前瞻性队列研究

Annals of Surgery
IF6.4
2025-09-260
OAAI
Ando, Koji MD, PhD; Hamabe, Atsushi MD, PhD; Nakamura, Yoshiaki MD, PhD; Watanabe, Jun MD, PhD; Hirata, Keiji MD, PhD; Kataoka, Kozo MD, PhD; Miyo, Masaaki MD, PhD; Kato, Kentaro MD; Akazawa, Naoya MD; Kagawa, Yoshinori MD, PhD; Yokota, Mitsuru MD, PhD; Yamazaki, Kentaro MD, PhD; Mishima, Saori MD, PhD; Yukami, Hiroki MD; Kotani, Daisuke MD, PhD; Bando, Hideaki MD, PhD; Laliotis, George MD, MHA, MPH, MBA; Sharma, Shruti PhD; Palsuledesai, Charuta C. PhD; Rabinowitz, Matthew PhD; Jurdi, Adham MD; Liu, Minetta C. MD; Aleshin, Alexey MD; Taniguchi, Hiroya MD, PhD; Takemasa, Ichiro MD, PhD; Kato, Takeshi MD, PhD; Yoshino, Takayuki MD, PhD; Oki, Eiji MD, PhD
Survival Outcomes of Patients with BRAF V600E-Mutant Resectable Extrahepatic Colorectal Oligometastases After Upfront Metastasectomy

BRAF V600E突变可切除性肝外结直肠癌寡转移患者行 upfront metastasectomy 术后的生存结局

JOURNAL OF GASTROINTESTINAL CANCER
IF1.6
2025-09-220
PRE
Mori, Takashi; Kobayashi, Shin; Tsukada, Yuichiro; Kojima, Motohiro; Kitaguchi, Daichi; Hasegawa, Hiro; Ikeda, Koji; Nishizawa, Yuji; Gotohda, Naoto; Bando, Hideaki; Tsuboi, Masahiro; Ito, Masaaki; Yoshino, Takayuki
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer

HIBRID：基于组织学的结直肠癌风险分层，结合深度学习和ctDNA

Nature Communications
IF15.7
2025-08-140
OAAI
Chiara M. L. Loeffler; Hideaki Bando; Srividhya Sainath; Hannah Sophie Muti; Xiaofeng Jiang; Marko van Treeck; Nic Gabriel Reitsam; Zunamys I. Carrero; Asier Rabasco Meneghetti; Tomomi Nishikawa; Toshihiro Misumi; Saori Mishima; Daisuke Kotani; Hiroya Taniguchi; Ichiro Takemasa; Takeshi Kato; Eiji Oki; Yuan Tanwei; Wankhede Durgesh; Sebastian Foersch; Hermann Brenner; Michael Hoffmeister; Yoshiaki Nakamura; Takayuki Yoshino; Jakob Nikolas Kather

研究方向

暂未获取到该数据
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:4.9万
E
Eiji Oki
H 指数:70论文数:1,185被引数:1.8万
Y
Yoshiaki Nakamura
H 指数:40论文数:669被引数:9,240
D
Daisuke Kotani
H 指数:26论文数:365被引数:4,070
H
Hiroya Taniguchi
H 指数:36论文数:433被引数:7,594
A
Atsushi Ohtsu
H 指数:90论文数:768被引数:4.2万
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
T
Takeshi Kato
H 指数:49论文数:664被引数:7,878
K
Kentaro Yamazaki
H 指数:46论文数:557被引数:1.4万